chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Losing hair; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A female patient received bnt162b2 (COMIRNATY) (Lot number: Not Provided) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "Losing hair".  Additional information: The report was not related to a study or programme. She reported her daughter had the Pfizer Vaccine for Covid at the same time as reporter did. She thought it started in October or the first of October-year, further date details and clarification of what 'it' was that started not provided. The reporter reported her daughter was losing her hair. Reporter couldn't figure it out. Reporter's daughter took Biotin which helped with her hair.  The lot number for vaccine [BNT162B2] was not provided and will be requested during follow-up.
Overwhelming tiredness for 2 days  Fatigue- Slept all through nights A little foggy mind Redness and swelling around site of injection- still demonstrating on third day March 4
pt recvd vax;fussy & unusual T;to er & T 105;ice bath given;fever came down w/ acetaminophen;spinal tap neg;red spots,rash noted on 17feb;resolved by 19feb;dx:viral infect found in blood cultures & possible Roseola;
Dizziness, Headache & NauseaVomiting Narrative:  Need to stay home due to N/V, missed work day.
Lt arm, deltoid area was red, swollen (measured 50mm x 60mm) warm to touch, painful; applied warm compresses; swelling gone by 22APR91;
This spontaneous report as received from a other health professional refers to patients of unknown age and gender. On unknown dates, the patients were vaccinated with PROQUAD lot # N008824 for prophylaxis. Concomitant therapies included sterile diluent. On unknown dates, the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event were unknown. The reporter considered incorrect product storage and no adverse event to be not related to PROQUAD. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA011267: US-009507513-1708USA005004.
This 64 year old white  male received the Covid shot on  1/21/21    and went to the ED on 2/7/21   with the following diagnoses listed below. U07.1 - COVID-19
severe headaches, body chills, fever, bone pain, joint pain, abd pain, vomiting, nausea,  sweating so much my bed sheets were damp . note: all symptoms were so severe I thought I was going to have to call off of work the next day. symptoms lasted about 12hrs
After receiving second Pfizer vaccine, I felt like I was under anesthesia for two days.  A few weeks later, I acquired a deep wheezing cough in my lungs that lasted for six months. No medical (pulmonologist, neurologist or rheumatalogist) could figure out what was happening to me.  I then landed in the hospital for a week (March of 2022) with a pneumonia in my lungs, onset sepsis and acute sinusitis.  At that time, I started experiencing numbness in my feet. A few weeks later, I ended up in the hospital for a month (May 2022).  Here they did a biopsy of my nerves and muscles and discovered a rare Vasculitis Granulamatosis with Polyangitis. An autoimmune disease that attacked my central nervous system.  I am learning to walk again and use my hands!
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 17-SEP-2013 the patient was vaccinated with M-M-R II (lot #H015829, expiration date 24-Aug-2014). The vaccine was exposed to temperature exposures of 52F, on 29-AUG-2013 for 40 minutes, on 09-SEP-2013 for 1 hr and 25 minutes, on 10-SEP-2013 for 15 minutes and on 17-SEP-2013 for 35 minutes. No known adverse effects. Additional information has been requested.
Inappropriate schedule of vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 044B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 28-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Received the second dose of Moderna covid-19 vaccine on 28Apr2021.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow-up information received on 29-JUN-2021 contains no new information. On 29-Jun-2021: Follow up received on 29-Jun-2021, no new information was recorded
Information has been received from a nurse practitioner concerning a female patient had no reaction after receiving her first dose of PNEUMOVAX 23 few years ago, who on 09-OCT-2009 was vaccinated with a second dose of PNEUMOV.5AX 23, 0.5 ml, SQ (Lot # not provided). Concomitant therapy included "anticholesterol medications". On 09-OCT-2009 the patient developed an injection site reaction after receiving PNEUMOVAX 23. The patient developed redness, pain and swelling on the injection site. The affected area was whole upper arm. The patient called the nurse practitioner. The patient recovered "3 days after the injection date". Additional information has been requested.
2 inch knot @ inj site PCP recommended benedryl & Ibuprofen
PT DEVELOPED DIFFICULTY BREATHING ABOUT 3 MINUTES AFTER THE INJECTION.  EPINEPHERINE 0.3MG INJECTED INTO LEFT THIGH. PT'S CONDITION IMPROVED AFTER ABOUT 3 MINUTES.  EMS CONTACTED AND MONITORED PTS CONDITION, REPORTING O2 SATS WERE WITHIN NORMAL LIMITS.  PT EVENTUALLY WAS TAKEN TO HOSPITAL WHERE PT REPORTED BEING GIVEN DIPHENHYDRAMINE AND PREDNISONE PLUS A PRESCRIPTION FOR PREDNISONE TO CONTINUE AT HOME.
Pt had large red/warm to touch injection site reaction from shoulder to elbow. Pt had fever and runny nose. Pt saw physician. Exact cause of fever and runny nose undetermined. No infection in arm.
Flu like symptoms: chills, aches, exhaustion until around 6pm (9 hours total). Took ibuprofen and Tylenol every few hours and slept to feel better.
Severe urgent diarrhea; Feels like she might be getting a little fever; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient  received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date unknown), via an unspecified route of administration to right deltoid (shoulder) on 15Jan2021 at around 10:30-10:40 AM at a single dose  for COVID-19 immunization.  Medical history included chronic fatigue syndrome, fibromyalgia, problems with her colon, back surgery, and flashes.  Concomitant medications included ibuprofen given on unspecified date for back surgery, and unspecified hormones, vitamins, and laxatives.  The patient previously received the flu vaccine on unspecified date and experienced like she got the flu and relapse of her chronic fatigue syndrome. She also received hepatitis C vaccine, hepatitis B vaccine, pneumonia vaccine, and shingles vaccine; all on unspecified dates. The patient had not received prior vaccinations within four weeks. On 15Jan2021, the patient experienced severe urgent diarrhea and felt like she might be getting a little fever. It was further described as: Patient had an odd reaction within maybe 30 minutes to 1 hour after that dose was administered of severe urgent diarrhea. Patient mentioned she felt like she might be getting a little fever; but she was not sure and did not have a thermometer to check that. Severe urgent diarrhea: She mentioned she had not seen that side effect posted anywhere for the vaccine so she felt it was an odd reaction; although she did see that it was a side effect of the virus, so maybe it was not that odd of a reaction for the vaccine now that she thought about it. She described this event as completely crazy, the urgency to go to the bathroom, she almost did not make it home to the bathroom. It just hit her like she has never experienced before. It cleaned out her colon really well. She also felt like she might be getting a little fever but mentioned that at her age she gets hormone flashes so it could be that; and was humid at the time of report and thought so it could just be from that. The outcome of the events was unknown.  Information regarding Batch/ Lot number has been requested.
Felt a lot of pain in left shoulder after tetanus shot. Went home needle injection site visible directly below acromion, really high up on shoulder. Had other injuries and hoped soreness would dissipate but 6 days later very painful and limited mobility. Feel may need to see doctor and possibly physical therapy.
fever; chills; sick; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a Consumer/Non-HCP.  This case involves female patient who experienced fever (pyrexia), chills (chills) and sick (malaise), while she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Breast cancer.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious fever (pyrexia), chills and sick (malaise) (Unknown latency) following the administration of INFLUENZA VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was sick, chills and fever.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for fever, chills and sick.  Information on the batch number was requested.  List of documents held by sender: none.
This case was reported by a consumer and described the occurrence of unresponsive to stimuli in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced unresponsive to stimuli (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the unresponsive to stimuli was unknown. It was unknown if the reporter considered the unresponsive to stimuli to be related to SHINGRIX. Additional information was reported as follows: This case was reported by a pharmacy via a pharmacy claims management company. The age at vaccination was unknown. The case was reported to seek indemnification for claims, regarding the events experienced by the patient after administration of SHINGRIX. It was stated that the patient became unresponsive after vaccination with SHINGRIX, and was further transported to the hospital. The reporter had requested claim from GlaxoSmithKline for the consequences suffered by the patient. The reporter further stated that, based on the available information, they had tendered this claim to GlaxoSmithKline for handling and denying liability.  They had requested to acknowledge their tender as soon as possible and confirm that GlaxoSmithKline or its liability insurance arrier will investigate the matter and thereafter advise the reporter's office as well as the involved pharamcy store. They had also requested to provide a copy of release to them for their records.
PLAQUE PSORIASIS BAD FLARE; FEVER AFTER TAKING COVID VACCINE; PAIN AFTER TAKING COVID VACCINE; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (PAIN AFTER TAKING COVID VACCINE), PSORIASIS (PLAQUE PSORIASIS BAD FLARE) and PYREXIA (FEVER AFTER TAKING COVID VACCINE) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 1 dosage form. In 2021, the patient experienced PAIN (PAIN AFTER TAKING COVID VACCINE) and PYREXIA (FEVER AFTER TAKING COVID VACCINE). In June 2022, the patient experienced PSORIASIS (PLAQUE PSORIASIS BAD FLARE). At the time of the report, PAIN (PAIN AFTER TAKING COVID VACCINE) and PYREXIA (FEVER AFTER TAKING COVID VACCINE) had resolved and PSORIASIS (PLAQUE PSORIASIS BAD FLARE) outcome was unknown.            No concomitant medication were provided  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's causality for the event of Plaque psoriasis bad flare because unable to get Sktrizi,Pain after taking COVID vaccine and fever after taking COVID vaccine had no reasonable possibility with Sktrizi.  No treatment details were provided
I experienced an inflammation of the gallbladder called cholecystitis - which caused pancreatitis.  My gallbladder was surgically removed.
I received my vaccine on August 22, 21 at 1;20 pm in my left deltoid.  I received the vaccine with my daughter  at the same pharmacy on the same day.  I was with my daughter  on August 23, 2021 taking her to the hospital as she was experiencing chest pain post vaccine. However I  also began to experience chest pain; on August 23, 21 at 1:30 pm I notice sudden heart palpitations that  quickly escalated and progressively got worse with sudden crushing chest pain, pain in bilateral shoulders and pain on the right and left side  my neck. You could visible notice that my heart was beating hard and  that my chest was "jumping"  I attended hospital but emergency room was too full   so  I went to emergency room at another hospital. At this time my heart rate presented at 217 beats per minute . Respiratory rate of 22, Blood pressure of 131/82 Temeprature 36. To reset my heart I was given Adenosine via  intravenous push . I remained in the hospital for the next 12 hours under assessment; had multiple blood work and ECG completed. I was diagnosed with new on set SVT-Super ventricular Tachycardia and refererd to clinic. I was also placed on Bisoprolol  Fumarate 2.5 mg daily.
This spontaneous report was received from a medical assistant concerning to multiple patients of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medication, were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M009378 for prophylaxis, expiration date: 23-APR-2018 for prophylaxis, which had a temperature excursion 32°F for 45 days. No previous temperature excursion were reported. The reporter stated that the temperature excursion was detected by a data logger. No product quality complaint was involved. This is one of several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA009041: US-009507513-1702USA009043: US-009507513-1702USA009044: US-009507513-1702USA009040: US-009507513-1702USA009042.
Patient received KINRIX and PROQUAD vaccinations at our clinic on 6/12/13. They were both given on the left arm. His mother brought him in 6/13/13 to show us a local reaction on the upper left arm. It was reddened and slightly swollen. He was itching, mom was instructed to give children's BENADRYL and cold compress and contact his physician if it did not improve.
within 1 week of 3rd moderna vaccination, this previously stable patient in clinical remission from her gastric cancer on immunotherapy developed painless jaundice, significant thrombocytopenia and elevations in Tbili/AST/ALT/alk phos
I received my 2nd COVID vaccine and within about 48 hours I lost a 3-inch diameter chunk of hair. Completely gone from the back of my head. I have never experienced any hair loss prior and had not been to a salon in over 3 months. After speaking to multiple doctors and specialists it is felt that this was hair loss due to an immune response from the COVID vaccine. There was no trauma to the area and no regrowth has occurred in the past 4 months.
pt came in and stated she was having redness, swelling, and heat in her arm at the injection site. She also stated that she had vomited multiple times the night before (the day of the vaccine). She also stated she felt very flu-like. I recommended she take benadryl, use ice and hydrocortisone cream topically.  I told her to stay hydrated and that I would call and check on her. I called her this evening she stated the redness was spreading despite the benadryl and ice and I asked her to let us know if she went to the doctor or the hospital.
First Hep A shot given in Feb. 2010. The physician administered 2nd Hep A shot in error on April 23, 2010, 4 months ahead of schedule. Doctor has since said patient will need blood test in 4 months to see if additional Hep A immunization is needed to provide immunity.
CEREBROVASCULAR ACCIDENT; SUSPECTED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; COAGULOPATHY; SARS-COV-2 TEST POSITIVE; This spontaneous report received from a health care professional via Regulatory Authority Vaccine Adverse Event Reporting System (VAERS reference number 1779560] concerned a 50 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 205A21A expiry: UNKNOWN) dose was not reported, frequency 1 total, administered on 07-APR-2021 to left arm for an unspecified indication. No concomitant medications were reported. On 21-SEP-2021, the patient experienced cerebrovascular accident, suspected clinical vaccination failure, confirmed covid-19 infection, coagulopathy and sars-cov-2 test positive. Laboratory data included: SARS-CoV-2 test (NR: not provided) positive. On 11-Oct-2021 date, the patient was hospitalized. Number of days of hospitalization was not reported. It was unknown if patient was discharged. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the confirmed covid-19 infection, cerebrovascular accident, coagulopathy, sars-cov-2 test positive and suspected clinical vaccination failure was not reported. This report was serious (Hospitalization Caused / Prolonged). This case was associated with product quality complaint number: 90000199058. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed.  Additional information received from Regulatory Authority department on 24-NOV-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result was added.; Sender's Comments: V1: Additional information in this version is regarding:  Product quality complaint investigation results. This does not alter company causality of previously reported events 20211046077-Covid-19 vaccine ad26.cov2.s-Cerebrovascular accident, Confirmed covid-19 infection, coagulopathy, sars-cov-2 test positive. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211046077-Covid-19 vaccine ad26.cov2.s- Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
DTaP given on 11/8/02. 3AM 11/9/02 fever 104; seen in ER. No other symptoms.
Headache started the day after vaccination and persisted, developed vesicular rash on left scalp
At first I had no idea what was going on and just thought I may have been going through a stage or just getting older, but ever since I got the shot I have symptoms of Guillian Barre syndrome meaning constant twitching of muscles that started in the legs and progressed through to my upper body and even my face and groin area, on top of this I have experienced a permanent state of fatigue, and loss of energy and control of my bowels and urination habbits. Sleeping at night is now no longer the same for me because of the uncomfortable state of my body and twitching of my muscles I can't relax anymore. There were 2 instances of waking up and not being able to remember how to walk I could not move my legs to walk. On top of all of this I get random headaches that I never got up until this last year.  Also it feels like my insides are twitching as well in my chest and stomach and groin area. It comes and goes but happens multiple times everyday ever since. The day after I got the Jannssen vaccine I couldn't sleep and when I laid down my body felt like it was under attack with cold sweats and my heart was racing like never before in my life. I'm not sure what the government is doing but I will NEVER get another vaccine again in my life.
R thigh redness, scab (infected) TX Augmentin 200/5 ml warm induration
encephalitis - dx 17Jun90-fever started 4Jun90, concurrent mycoplasma pneumonia.
Pt received dose 2 of 2 dose series of Pfizer COVID-19 vaccination at 1200 on 1/25/2021. At 1220, pt. reported "tingly feeling on tongue" and swelling of lips. NP notified and assessed pt. Benadryl advised, but pt. refused 50 mg of IM Benadryl because it has cholinergic effect, leading to agitation, tachycardia, racing thoughts. Pt. advised to stay under observation until symptoms resolved fully. At 13:02, at time of filling out form, pt. reported symptoms had decreased, denies tingling of tongue.